Mercy Clinic Oklahoma Communities Inc-Norman
Norman, Oklahoma, United States
Medical clinic in Norman, Oklahoma
950 N. Porter Avenue Suite 100, 200 & 300, Norman, OK 73071
About Mercy Clinic Oklahoma Communities Inc-Norman
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Mercy Clinic Oklahoma Communities Inc-Norman
During the past decade, Mercy Clinic Oklahoma Communities Inc-Norman conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma
1996-11-01
2010-12-01
Completed
77
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1999-04-01
2016-05-01
Completed
854
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
1998-12-01
2025-10-01
Active, not recruiting
1,150
S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
1999-10-15
2018-05-01
Completed
983
S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
2000-08-01
2012-07-01
Completed
432
S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma
2001-03-01
2023-06-01
Active, not recruiting
571
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
2000-10-01
2019-11-01
Completed
1,772
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Clinic Oklahoma Communities Inc-Norman"
#1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Mercy Clinic Oklahoma Communities Inc-Norman
According to Clinical.Site data, the most researched conditions in "Mercy Clinic Oklahoma Communities Inc-Norman" are
"Colorectal Cancer" (1 trials) and "Lung Cancer" (1 trials). Many other conditions were trialed in "Mercy Clinic Oklahoma Communities Inc-Norman" in a lesser frequency.
Clinical Trials Intervention Types at Mercy Clinic Oklahoma Communities Inc-Norman
Most popular intervention types in "Mercy Clinic Oklahoma Communities Inc-Norman" are "Drug" (2 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "celecoxib" (2 trials), "placebo" (2 trials), "5-fluorouracil" (1 trials), "carboplatin" (1 trials) and "gemcitabine hydrochloride" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Mercy Clinic Oklahoma Communities Inc-Norman
The vast majority of trials in "Mercy Clinic Oklahoma Communities Inc-Norman" are
2 trials for "All" genders.
Clinical Trials Status at Mercy Clinic Oklahoma Communities Inc-Norman
Currently, there are NaN active trials in "Mercy Clinic Oklahoma Communities Inc-Norman".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Mercy Clinic Oklahoma Communities Inc-Norman,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Mercy Clinic Oklahoma Communities Inc-Norman, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".